Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-005425
Filing Date
2019-03-01
Accepted
2019-03-01 16:15:26
Documents
1
Period of Report
2019-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4285
  Complete submission text file 0000899243-19-005425.txt   5847
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Zago Wagner M. (Reporting) CIK: 0001708681 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 19649519